Dernières nouvelles pour DarioHealth (NASDAQ:DRIO) Stock

DarioHealth

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

DarioHealth Corp

RBC Capital analyst Gregory Renza maintains Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) with a Outperform and lowers the price target from $68 to $48.

News

Price Target

Analyst Ratings

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

RBC Capital Maintains Outperform on Jasper Therapeutics, Lowers Price Target to $48

Barclays analyst Karen Short maintains Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Overweight and lowers the price target from $102 to $100.

Barclays Maintains Overweight on Dollar Gen, Lowers Price Target to $100

Barclays analyst Seth Sigman maintains Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) with a Equal-Weight and lowers the price target from $8 to $7.

BYON

Barclays Maintains Equal-Weight on Beyond, Lowers Price Target to $7

Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) owned search giant Google is the latest tech company to donate to Donald Trump's inauguration fund ahead of the highly anticipated<a href="https://www.benzinga.com/25/01/42801809/apple-ceo-tim-cook-reportedly-donates-1-million-to-trump-inauguration-joins-ranks-of-mark-zuckerberg-jeff-bezos-and-sam-altman"> Jan. 20 event.</a>
What Happened: Google announced a $1 million donation to Trump's inauguration,<a href="https://www.benzinga.com/general/politics/24/07/39826475/trumps-new-running-mate-j-d-vance-wants-to-break-up-google-could-2024-election-be-bad-for-big-te"> joining the ranks</a> of Meta Platforms, Amazon.com, Ford Motor Company and more.
Several tech billionaires including Apple CEO Tim Cook and OpenAI CEO Sam Altman have also announced $1 million donations on their own and not directly from their associated companies.
The donation by Google made on Monday was confirmed by <a href="https://www.politico.com/live-updates/2025/01/09/congress/google-donation-donald-trump-inauguration-00197233">Politico </a>on Thursday and comes as Alphabet CEO Sundar Pichai was among the tech moguls who met with Trump at Mar-A-Lago since his 2024 presidential election win.
"Google is pleased to support the 2025 inauguration, with a livestream on YouTube and a direct link on our homepage. We're also donating to the inaugural committee," Google's global head of government affairs and public policy Karen Bhatia told Politico.
Google previously donated $285,000 to the 2016 and 2020 inaugurations, a spokesperson told Politico. Google also previously promoted the inauguration on its homepage and YouTube.
Read Also: <a href="https://www.benzinga.com/24/12/42660866/trump-gets-ford-vehicles-1m-for-inauguration-will-musk-respond-or-could-he-ride-in-rival-vehicle">Trump Gets Ford Vehicles, $1M For Inauguration &#8211; Will Musk Respond Or Could He Ride In Rival Vehicle?</a>
Why It's Important: The donation from Google comes as the company has been targeted by the Department of Justice for <a href="https://www.benzinga.com/tech/24/11/42140450/doj-targets-google-chrome-poll-shows-64-oppose-alphabet-breakup-youtube-seen-as-top-prize">alleged monopolistic behavior </a>and could be forced to break up and spinoff assets like the Chrome browser.
While there's no certainty that a donation or a visit to Mar-A-Lago will sway the new administration or prevent such outcomes, changes to the DOJ&#8217;s leadership could potentially shift the company&#8217;s legal challenges.
Incoming Vice President J.D. Vance also previously said he <a href="https://www.benzinga.com/general/politics/24/07/39826475/trumps-new-running-mate-j-d-vance-wants-to-break-up-google-could-2024-election-be-bad-for-big-te">wants to break up </a>Google, which could make the company a target of the new administration.
Senator Ted Cruz (R-Texas) recently told Politico that Republicans would target Google's content moderation policies on the search engine and on YouTube.
GOOG Price Action: Alphabet stock closed at $195.39 Wednesday versus a 52-week trading range of $131.55 to $202.88. Alphabet stock is up 37% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/management/25/01/42880549/nvidia-ceo-jensen-huang-wants-to-congratulate-trump-at-mar-a-lago-but-hasnt-been-invited-yet">Nvidia CEO Jensen Huang Wants To Congratulate Trump At Mar-A-Lago, But Hasn&#8217;t Been Invited Yet</a></li>
</ul>
Photo: Shutterstock

Politics

Tech

GOOG

GOOGL

Google Donates $1 Million To Trump Inauguration, Plans YouTube Livestream: 'Pleased To Support'

RBC Capital analyst Daniel Perlin reiterates Flywire (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) with a Outperform and maintains $25 price target.

Reiteration

FLYW

RBC Capital Reiterates Outperform on Flywire, Maintains $25 Price Target

Barclays analyst Seth Sigman maintains Best Buy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) with a Equal-Weight and lowers the price target from $95 to $89.

Barclays Maintains Equal-Weight on Best Buy Co, Lowers Price Target to $89

RBC Capital analyst Brian Abrahams reiterates Contineum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) with a Outperform and maintains $31 price target.

CTNM

RBC Capital Reiterates Outperform on Contineum Therapeutics, Maintains $31 Price Target

Barclays analyst Matthew McClintock maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Overweight and raises the price target from $3024 to $3585.

Barclays Maintains Overweight on AutoZone, Raises Price Target to $3585

Barclays analyst Seth Sigman maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Equal-Weight and lowers the price target from $66 to $54.

Barclays Maintains Equal-Weight on Advance Auto Parts, Lowers Price Target to $54

RBC Capital analyst Steven Shemesh reiterates Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Outperform and maintains $22 price target.

RBC Capital Reiterates Outperform on Albertsons Companies, Maintains $22 Price Target

RBC Capital analyst Sam Crittenden reiterates Capstone Copper (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CS#TSX">CS</a>) with a Outperform and maintains C$12 price target.

TSX:CS

RBC Capital Reiterates Outperform on Capstone Copper, Maintains C$12 Price Target

Unum Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>) has outperformed the market over the past 5 years by 7.91% on an annualized basis producing an average annual return of 20.39%. Currently, Unum Gr has a market capitalization of $13.32 billion. 
Buying $1000 In UNM: If an investor had bought $1000 of UNM stock 5 years ago, it would be worth $2,512.92 today based on a price of $72.95 for UNM at the time of writing.
<h3>Unum Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736435709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Unum Gr 5 Years Ago Would Be Worth This Much Today

On Thursday, Nokia Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) disclosed that Openreach has selected its One Network Platform to build an open-<a target="_blank" href="https://www.globenewswire.com/news-release/2025/01/09/3006821/0/en/Nokia-and-Openreach-introduce-intent-based-networking-to-build-an-open-access-network-accelerating-UK-fiber-broadband-rollout.html" rel="noreferrer noopener">access </a>fiber network across the U.K.
Nokia&#8217;s solution is projected to enable Openreach to build a large-scale, multi-service network with lower power and space requirements. The architecture supports various deployment models, ensuring providers can seamlessly connect users to Openreach&#8217;s fiber network.
Notably, Openreach&#8217;s broadband network connects users to around 300 providers, offering high-speed fiber services in cities, towns, villages, and remote areas across the U.K.
Nokia&#8217;s One Network Platform helps meet the growing demand by offering flexibility and scale, while reducing the number of exchange buildings needed.
Built using Nokia&#8217;s One Network Platform, the network will enable Openreach to achieve its goal of connecting 25 million premises by the close of 2026, addressing the growing demand for high-speed broadband.
Using Nokia&#8217;s Altiplano and NSP network controllers, Openreach can automate fiber connectivity and simplify operations with a unified service interface and reduces OSS complexity by 85%, while providing real-time telemetry for better network performance insights.
Last week, Nokia, along with Intuitive Machines, Inc., successfully integrated the Lunar Surface Communication System into <a target="_blank" href="https://www.benzinga.com/25/01/42856421/from-earth-to-the-moon-intuitive-machines-and-nokia-launch-4glte-network" rel="noreferrer noopener">the&nbsp;IM-2 mission lander, Athena</a>.
Investors can gain exposure to NOK stock via&nbsp;iShares U.S. Digital Infrastructure and Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDGT#NYSE">IDGT</a>) and&nbsp;First Trust Indxx NextG ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTG#NASDAQ">NXTG</a>).
Price Action: NOK shares closed higher by 0.65% at $4.66 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/24/12/42535215/nokia-supercharges-indias-broadband-with-ishan-tech-taps-zscaler-to-upgrade-cloud-protection" target="_blank" rel="noreferrer noopener">Nokia Supercharges India&#8217;s Broadband with Ishan Tech; Taps Zscaler To Upgrade Cloud Protection</a></li>
</ul>

Equities

iShares U.S. Digital Infrastructure and Real Estate ETF

IDGT

NXTG

Openreach Taps Nokia For UK Fiber Expansion: Details

RBC Capital analyst Darko Mihelic upgrades Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) from Sector Perform to Outperform and raises the price target from C$97 to C$103.

Upgrades

TSX:CM

RBC Capital Upgrades Canadian Imperial Bank to Outperform, Raises Price Target to C$103

RBC Capital analyst Darko Mihelic upgrades Canadian Imperial Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) from Sector Perform to Outperform and raises the price target from $97 to $103.

RBC Capital Upgrades Canadian Imperial Bank to Outperform, Raises Price Target to $103

RBC Capital analyst Darko Mihelic upgrades Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) from Sector Perform to Outperform and raises the price target from $133 to $161.

RBC Capital Upgrades Bank of Montreal to Outperform, Raises Price Target to $161

RBC Capital analyst Darko Mihelic upgrades Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) from Sector Perform to Outperform and raises the price target from C$133 to C$161.

TSX:BMO

RBC Capital Upgrades Bank of Montreal to Outperform, Raises Price Target to C$161

General

Real Estate

NMRK

Newmark Group Has Arranged The $360M Sale Of Two Park Avenue In Manhattan. The Transaction Is The Largest Advisor-led, All-office Property Sale In New York City In 2024

ARCH

CEIX

Arch Resources, CONSOL Energy Stockholders Vote To Approve All Proposals In Relation To Pending Combination

Treatment with ECUR-506 resulted in a complete clinical response from three months post exposure to the end of study (six months post exposure)
- ECUR-506 was generally well tolerated with no significant clinical safety concerns
- Insertion of a functional OTC gene through ARCUS in vivo gene editing may provide lasting clinical benefit for children with OTC deficiency who are in dire need of effective treatments

Biotech

Health Care

DTIL

Precision Biosciences' Partner iECURE Has Reported Clinical Efficacy And Safety Data In The First Patient Dosed With ECUR-506 In The Phase 1/2 OTC-HOPE Study

DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript

DarioHealth (DRIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Rhyee from TD Co...

DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability

Dario signs new regional health plan

DarioHealth (DRIO) announced a new collaboration with a pharma company that will utilize Dario Connect among their patient populations to further t...

DarioHealth announces new collaboration with pharma company

DarioHealth GAAP EPS of $0.25 beats by $0.52, revenue of $7.42M beats by $0.02M

Reports Q3 revenue $7.42M, consensus $7.4M. "Our third quarter included strong execution of our multi-year strategic plan of being a profitable pro...

DarioHealth reports Q3 EPS (25c), consensus (27c)

DarioHealth ( ($DRIO) ) has released its Q3 earnings. Here is a breakdown of the information DarioHealth presented to its investors. DarioHealth Co...

DarioHealth Earnings Reflect Growth Amid Challenges

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on DarioHealth (DRIO – Research Report). The associated price target was lowered...

Positive Outlook for DarioHealth Driven by B2B2C Growth and Strategic Partnerships

DarioHealth (DRIO) announced the signing of four contracts with self-insured employers that are expected to go live in the first quarter of 2025. D...

Comments

DarioHealth

Actualités

Dernières nouvelles pour DarioHealth (NASDAQ:DRIO) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL